A pandemic of the novel coronavirus has now killed more than 1.3 million people worldwide.
Over 53.2 million people across the globe have been diagnosed with COVID-19, the disease caused by the new respiratory virus, according to data compiled by the Center for Systems Science and Engineering at Johns Hopkins University. The actual numbers are believed to be much higher due to testing shortages, many unreported cases and suspicions that some national governments are hiding or downplaying the scope of their outbreaks. The criteria for diagnosis -- through clinical means or a lab test -- has also varied from country to country.
Since the first cases were detected in China in December, the virus has rapidly spread to every continent except Antarctica. The United States is the worst-affected nation, with more than 10.7 million diagnosed cases and at least 244,283 deaths.
Nearly 200 vaccine candidates for COVID-19 are being tracked by the World Health Organization, at least 10 of which are in crucial phase three studies. Of those 10 potential vaccines in late-stage trials, there are currently five that will be available in the United States if approved.
Here's how the news is developing. All times Eastern.
Nov 10, 2020, 4:19 PM EST
Antibody drug can keep patients out of hospital but should be reserved for high-risk: Officials
Eli Lilly's FDA-authorized monoclonal antibody drug takes an hour to infuse via IV and should be reserved for those at high-risk of getting sicker, senior government officials said at a briefing Tuesday.
This photo provided by Eli Lilly shows the drug Bamlanivimab. On Nov. 9, 2020, the FDA cleared emergency use of Bamlanivimab, the first antibody drug to help the immune system fight COVID-19. The drug is for people 12 and older with mild or moderate COVID-19 not requiring hospitalization.
Courtesy of Eli Lilly via AP
High-risk includes people with preexisting conditions like obesity, chronic kidney disease, diabetes and those older than 65.
Government officials said they hope the drug will help slow down hospitalizations.
The product’s distribution will begin this week with over 80,000 doses. The government has a contract to purchase 300,000 doses through December, with the option to purchase another 650,000 through June.
ABC News' Sony Salzman contributed to this report
Nov 10, 2020, 3:49 PM EST
Cases increasing 'exponentially' in Midwest
COVID-19 cases in the Midwest have increased “exponentially over the last four weeks,” according to Dr. Amy Williams, dean of the Mayo Clinic Practice in Minnesota.
The positivity percentage is now hovering around 20% in some Minnesota communities and over 30% in some Wisconsin towns, she said.
A medical assistant at St. Luke's Respiratory Clinic in Duluth, Minnesota administers a COVID-19 test to a patient in their drive-through testing site, Nov. 3, 2020.
Alex Kormann/Minneapolis Star Tribune/Newscom
When the rate of positivity “is over 10%, which is very, very serious… we start to worry about having the capacity to care for those that are positive," she said.
“Younger and younger patients" are also being hospitalized, she noted.
ABC News' Arielle Mitropoulos contributed to this report
Nov 10, 2020, 3:34 PM EST
New restrictions coming to San Diego, Sacramento
In California, COVID-19 numbers are on the rise.
In October the state had a 14-day positivity rate average of 2.9%. Now, the 14-day average is up to 3.7%.
Jorge Angel Llamas, left, takes a COVID-19 test under the supervision of nurse Karen Barringer in Chula Vista, Calif., Aug. 28, 2020.
San Diego Union-Tribune/Sipa via USA Today Network, FILE
California's Sacramento, San Diego and Stanislaus counties are moving to the most restrictive COVID-19 tier, in which the rules include no indoor dining or gyms, officials announced Tuesday. Los Angeles County is already in the most restrictive tier.
The state’s top doctor is warning Californians to avoid Thanksgiving celebrations with people outside their household.
ABC News' Alex Stone contributed to this report
Nov 10, 2020, 2:50 PM EST
New restrictions in New Jersey after 'devastating' numbers
New Jersey Gov. Phil Murphy announced new restrictions on Tuesday following "devastating" COVID-19 numbers.
The state has 3,877 new COVID-19 cases, he said, bringing its total to over 260,000.
Newark, the state’s largest city, has a positivity rate at 19%.
"We’re taking action to beat back the second wave," Murphy said.
Beginning this Thursday, restaurants and bars can't operate indoors between 10 p.m. and 5 a.m. Sitting at the physical bar inside bars will be prohibited at all hours, Murphy said.
Diners are seen eating indoors at the Greek Taverna on Nov. 09, 2020, in Edgewater, N.J. New Jersey Gov. Phil Murphy announced that restaurants and bars must conclude indoor dining by 10 p.m. starting Nov. 12 to combat rising COVID-19 rates.
Michael Loccisano/Getty Images
"Due to the impact this may have on restaurants with small seating areas, restaurants will be allowed to have groups at tables indoors that are closer than six feet together, if they are separated by barriers that comply with guidance from the Department of Health," Murphy's statement said. "Restaurants will be allowed to set up plastic domes outdoors, limited to one group each, as additional outdoor dining space."
A waiter in a protective face mask takes a customer's order during lunch at a restaurant in Hoboken, N.J., Sept. 4, 2020. On Nov. 9, New Jersey Gov. Phil Murphy said bars and restaurants must halt indoor dining from 10 p.m. to 5 a.m. beginning Nov. 12 in an attempt to control a resurgence of the coronavirus.
Eduardo Munoz Alvarez/AP
Additionally, all indoor sports games for high schoolers and younger will be banned.